Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure

View source ↗

Summary

A pediatric trial assessing azilsartan in children aged 6 to under 16 with hypertension has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azilsartan (azilsartan)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Status: COMPLETED | Results posted: 2025-09-10